{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T04:28:34Z","timestamp":1792384114792,"version":"4.4.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ejmech.2023.116029","type":"journal-article","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T02:39:48Z","timestamp":1702003188000},"page":"116029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Design, synthesis and evaluation of novel UDCA-aminopyrimidine hybrids as ATX inhibitors for the treatment of hepatic and pulmonary fibrosis"],"prefix":"10.1016","volume":"264","author":[{"given":"Yue","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuoyu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongmei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.116029_bib1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: from mechanisms to medicines","volume":"587","author":"Henderson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.116029_bib2","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMra1300575","article-title":"Fibrosis - a common pathway to organ injury and failure","volume":"12","author":"Rockey Dc","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2023.116029_bib3","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1183\/09031936.00185114","article-title":"Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review","volume":"46","author":"Hutchinson","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejmech.2023.116029_bib4","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-015-0165-1","article-title":"Clinical and economic burden of idiopathic pulmonary fibrosis: a retrospective cohort study","volume":"16","author":"Raimundo","year":"2016","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.ejmech.2023.116029_bib5","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3390\/life13020486","article-title":"Trials and treatments: an update on pharmacotherapy for idiopathic pulmonary fibrosis","volume":"13","author":"Thong","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.ejmech.2023.116029_bib6","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3389\/fphar.2017.00855","article-title":"Drugs and targets in fibrosis","volume":"8","author":"Li","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.116029_bib7","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.3390\/molecules28093674","article-title":"Recent advances (2015-2020) in drug discovery for attenuation of pulmonary fibrosis and COPD","volume":"28","author":"Dorababu","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.116029_bib8","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"22","author":"Richeldi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2023.116029_bib9","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/resp.13024","article-title":"Pirfenidone and nintedanib for pulmonary fibrosis in clinical practice: tolerability and adverse drug reactions","volume":"22","author":"Galli","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.ejmech.2023.116029_bib10","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12931-021-01857-y","article-title":"Pirfenidone vs. Nintedanib in patients with idiopathic pulmonary fibrosis: a retrospective cohort study","volume":"22","author":"Marijic","year":"2021","journal-title":"Respir. Res."},{"key":"10.1016\/j.ejmech.2023.116029_bib11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1083\/jcb.200204026","article-title":"Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production","volume":"158","author":"Umezu-Goto","year":"2002","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejmech.2023.116029_bib12","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M205623200","article-title":"Identification of human plasma lysophospholipase d, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase","volume":"277","author":"Tokumura","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.116029_bib13","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1194\/jlr.R046458","article-title":"LPA receptor signaling: pharmacology, physiology, and pathophysiology","volume":"55","author":"Yung","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejmech.2023.116029_bib14","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.3390\/cancers11101577","article-title":"The structural binding mode of the four autotaxin inhibitor types that differentially affect catalytic and Non-Catalytic functions","volume":"11","author":"Salgado-Polo","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2023.116029_bib15","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/hep.28973","article-title":"Hepatocyte autotaxin expression promotes liver fibrosis and cancer","volume":"65","author":"Kaffe","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2023.116029_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pupt.2018.08.003","article-title":"Pharmacologic targeting of the ATX\/LPA axis attenuates bleomycin-induced pulmonary fibrosis","volume":"52","author":"Ninou","year":"2018","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2023.116029_bib17","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1165\/rcmb.2012-0004OC","article-title":"Pulmonary autotaxin expression contributes to the pathogenesis of pulmonary fibrosis","volume":"47","author":"Oikonomou","year":"2012","journal-title":"Am. J. Resp. Cell Mol."},{"key":"10.1016\/j.ejmech.2023.116029_bib18","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fmed.2018.00180","article-title":"Autotaxin in pathophysiology and pulmonary fibrosis","volume":"5","author":"Ninou","year":"2018","journal-title":"Front. Med."},{"key":"10.1016\/j.ejmech.2023.116029_bib19","doi-asserted-by":"crossref","first-page":"5604","DOI":"10.1021\/acs.jmedchem.5b01599","article-title":"Development of autotaxin inhibitors: an overview of the patent and primary literature","volume":"59","author":"Castagna","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116029_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11248","article-title":"Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signalling","volume":"7","author":"Keune","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2023.116029_bib21","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1021\/acs.jmedchem.6b01743","article-title":"Rational design of autotaxin inhibitors by structural evolution of endogenous modulators","volume":"60","author":"Keune","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116029_bib22","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1021\/acsmedchemlett.6b00207","article-title":"Novel autotaxin inhibitors for the treatment of osteoarthritis pain: lead optimization via Structure-Based drug design","volume":"7","author":"Jones","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.116029_bib23","series-title":"A Method for Selective Dehalogenation of Pyrimidine Rings","author":"Zhu","year":"2016"},{"key":"10.1016\/j.ejmech.2023.116029_bib24","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1021\/acschemneuro.7b00153","article-title":"Design, synthesis, and structure-activity relationship of tetrahydropyrido[4,3-d]pyrimidine derivatives as potent smoothened antagonists within vivo activity","volume":"8","author":"Lu","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2023.116029_bib25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/08977194.2011.595714","article-title":"TGF-\u03b2 signaling in fibrosis","volume":"29","author":"Biernacka","year":"2011","journal-title":"Growth Factors"},{"key":"10.1016\/j.ejmech.2023.116029_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.730176","article-title":"Liver fibrosis: therapeutic targets and advances in drug therapy","volume":"9","author":"Tan","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejmech.2023.116029_bib27","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1136\/annrheumdis-2016-210821","article-title":"Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension","volume":"76","author":"Avouac","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejmech.2023.116029_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102609","article-title":"NADPH oxidase 4 is dispensable for skin myofibroblast differentiation and wound healing","volume":"60","author":"Siedlar","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejmech.2023.116029_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175366","article-title":"Dehydrozingerone ameliorates thioacetamide-induced liver fibrosis via inhibition of hepatic stellate cells activation through modulation of the MAPK pathway","volume":"937","author":"Sharma","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.116029_bib30","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3390\/cells9030558","article-title":"Src inhibition attenuates liver fibrosis by preventing hepatic stellate cell activation and decreasing connective tissue growth factor","volume":"9","author":"Seo","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2023.116029_bib31","series-title":"Golm1 and the Role of Autophagy in Pulmonary Fibrosis [Doctoral Degree]","author":"Wang","year":"2022"},{"key":"10.1016\/j.ejmech.2023.116029_bib32","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1097\/01.CCM.0000057901.92381.75","article-title":"Transforming growth factor-beta: a mediator of cell regulation in acute respiratory distress syndrome","volume":"31","author":"Dhainaut","year":"2003","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejmech.2023.116029_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114918","article-title":"Design, synthesis and biological evaluation of novel diarylacylhydrazones derivatives for the efficient treatment of idiopathic pulmonary fibrosis","volume":"245","author":"Su","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116029_bib34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.abb.2018.01.006","article-title":"Baicalin inhibits pressure overload-induced cardiac fibrosis through regulating AMPK\/TGF-\u03b2\/Smads signaling pathway","volume":"640","author":"Xiao","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2023.116029_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109527","article-title":"Roxarsone inhibits hepatic stellate cell activation and ameliorates liver fibrosis by blocking TGF-\u03b21\/Smad signaling pathway","volume":"114","author":"Li","year":"2023","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejmech.2023.116029_bib36","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fphar.2017.00461","article-title":"Targeting TGF-\u03b2 mediated SMAD signaling for the prevention of fibrosis","volume":"8","author":"Walton","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.116029_bib37","first-page":"104","article-title":"Effects of novel fufang biejia ruangan tablets with sheep placenta as substitute for hominis placenta on CCl4-induced liver fibrosis","volume":"14","author":"Shen","year":"2022","journal-title":"Chin. Herb. Med."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423009960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423009960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:03:53Z","timestamp":1759331033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423009960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":37,"alternative-id":["S0223523423009960"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.116029","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and evaluation of novel UDCA-aminopyrimidine hybrids as ATX inhibitors for the treatment of hepatic and pulmonary fibrosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.116029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116029"}}